Malignant Urinary Tract Neoplasm — Trials

Malignant Urinary Tract Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,955 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 507
Recruiting: 271
Ph III recruiting: 36
Growth YoY: +23.2%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (246)

clinicaltrialsPublishedShowing 101–150 of 382 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06417190	Bladder Preservation for Patients With Muscle Invasive Bladder Cancer (MIBC) With Variant Histology	recruiting	Phase 2	20	Leslie BallasOTHER	1	Aug 6, 2026	clinicaltrials
NCT05176483	Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors(STELLAR-002)	recruiting	Phase 1	1,394	ExelixisINDUSTRY	13	Aug 5, 2026	clinicaltrials